{
  "id" : "extension_bds",
  "algorithm" : "eod_public",
  "version" : "3.3",
  "name" : "EOD Primary Tumor",
  "title" : "EOD Primary Tumor",
  "notes" : "**Note 1:** **Multiple simultaneous tumors** \n* In the case of multiple simultaneous tumors, code the tumor with the greatest extension.\n\n**Note 2:** **In transit metastases** \n* In transit metastasis is defined as a tumor distinct from the primary lesion and located either between the primary lesion and the draining regional lymph node(s) or distal to the primary lesion. \n* In transit metastasis with positive lymph node(s) are coded under EOD Regional Nodes.",
  "footnotes" : "(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998\n\n(2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.\n\n(3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL)\n\n(4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017\n\n(5) Bichakjian, C.K., Nghiem, P., Sober, A.J., et al. **Merkel Cell Carcinoma**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017",
  "last_modified" : "2025-09-18T20:52:30.506Z",
  "definition" : [ {
    "key" : "eod_primary_tumor",
    "name" : "Code",
    "type" : "INPUT"
  }, {
    "key" : "description",
    "name" : "Description",
    "type" : "DESCRIPTION"
  }, {
    "key" : "ss2018_t",
    "name" : "SS2018 T",
    "type" : "ENDPOINT"
  } ],
  "rows" : [ [ "000", "In situ, intraepidermal, intraepithelial, noninvasive", "VALUE:IS" ], [ "100", "Confined to site of origin\n* Lesion(s) confined to dermis\n* Subcutaneous tissue (through entire dermis)\n\nLocalized, NOS", "VALUE:L" ], [ "400", "Direct extension to\n- Bone\n- Cartilage\n- Fascia\n- Skeletal muscle", "VALUE:RE" ], [ "700", "Further contiguous extension", "VALUE:D" ], [ "800", "No evidence of primary tumor", "VALUE:U" ], [ "999", "Unknown; extension not stated\nPrimary tumor cannot be assessed\nNot documented in medical record\n\nDeath Certificate Only", "VALUE:U" ] ]
}